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Evaluating Retinal Function in Age-Related Maculopathy
with the ERG Photostress Test
Alison M. Binns and Tom H. Margrain
PURPOSE. To evaluate the diagnostic potential of the electroreti-
nogram (ERG) photostress test and the focal cone ERG in
age-related maculopathy (ARM).
METHODS. The cohort comprised 31 patients with ARM and 27
age-matched control subjects. The ERG photostress test was
used to monitor cone adaptation after intense light adaptation.
Focal 41- and 5-Hz cone ERGs were recorded monocularly
(central 20°) to assess steady state retinal function. Univariate
analysis identified electrophysiological parameters that differed
between groups, and receiver operating characteristic (ROC)
curves were constructed to assess their diagnostic potential.
Logistic regression analysis determined the diagnostic potential
of a model incorporating several independent predictors of
ARM.
RESULTS. The rate of recovery of the ERG photostress test was
reduced (recovery was slower) in subjects with ARM. The
parameter exhibited good diagnostic potential (P 0.002, area
under ROC curve  0.74). The implicit times of the 5-Hz
(a-wave, P  0.002; b-wave, P  0.001) and the 41-Hz (P 
0.001) focal cone ERGs were increased, and the 41-Hz focal
cone ERG amplitude (P  0.003) and focal to full-field ampli-
tude ratio (P  0.001) were reduced in the ARM group.
Logistic regression analysis identified three independent pre-
dictors of ARM, including the rate of recovery of the ERG
photostress test.
CONCLUSIONS. Early ARM has a marked effect on the kinetics of
cone adaptation. The clinical application of the ERG photo-
stress test increases the sensitivity and specificity of a model for
the diagnosis of ARM. Improved assessment of the functional
integrity of the central retina will facilitate early diagnosis and
evaluation of therapeutic interventions. (Invest Ophthalmol
Vis Sci. 2007;48:2806–2813) DOI:10.1167/iovs.06-0392
Age-related macular degeneration (AMD) is a condition thataffects the photoreceptors, retinal pigment epithelium
(RPE), Bruch’s membrane, and choriocapillaris. It is the prin-
cipal cause of blindness in the developed world and currently
affects approximately 12.7 million people in Europe and North
America.1,2 Age-related maculopathy (ARM) is a term applied
to the early stages of the AMD disease process, in which visual
acuity is often normal.3
Given the substantial social and economic impact of the
disease, it is not surprising that there is a considerable research
effort to develop therapeutic interventions (e.g., photody-
namic therapy,4 transpupillary thermotherapy,5 radiation ther-
apy6 pharmacologic therapy,7 and surgical intervention8). Sen-
sitive measures of retinal function are an essential requirement
to assess the efficacy of these interventions and for the early
identification of at-risk individuals.
Electrodiagnostic tests are capable of evaluating subtle ab-
normalities in central retinal function and have a role in the
assessment of ARM and AMD. Previous studies have shown that
ARM and AMD are associated with a reduction in response
amplitude and an increase in latency of the steady state focal
cone ERG and the multifocal cone ERG,9–16 which is consis-
tent with histologic and psychophysical evidence of cone
loss.17–20 Anatomic and psychophysical evidence suggests that
parafoveal rods are also affected in ARM,17–19 and these find-
ings are supported by the presence of prolonged response
latencies21 and reduced amplitudes22 in the multifocal rod
ERG.
Procedures that evaluate the kinetics of cone and rod adap-
tation, may be even more sensitive to ARM than are steady state
measures of visual function.23,24 However, obtaining objective
electrophysiological measures of the kinetics of rod adaptation
is technically challenging. For example, although central rods
are affected in ARM18,25,26 their lack of directional sensitivity
makes the recording of focal rod responses problematic.27 An
additional difficulty in the clinic is that rod dark adaptation is a
slow process.
Conversely, the kinetics of cone adaptation are relatively
fast. The visual evoked potential (VEP) has been used to obtain
an objective measure of cone adaptation.28,29 However, the
VEP reflects the activity of the entire visual pathway, and
postretinal disease delays its recovery,29 limiting the value of
this measure in outer retinal diseases such as ARM. The ERG
photostress test monitors the recovery of the focal 41-Hz ERG
after a period of intense light adaptation.30 The first harmonic
of the 41-Hz flicker ERG is dominated by bipolar cell activ-
ity,31–34 and so provides a more direct measure of outer retinal
function than does the VEP. The recovery of the 41-Hz ERG is
primarily dependent on photopigment regeneration,30 and
hence the ERG photostress test may have an important role in
the evaluation of ARM and AMD.
The purpose of this study was to assess the efficacy of the
ERG photostress test at detecting early functional changes in
ARM, compared with ERG measures of steady state cone func-
tion. In this report, we will demonstrate that the rate of recov-
ery of the ERG photostress test provides good discrimination
between participants with ARM and age-matched control sub-
jects, and is a significant parameter in a multivariate diagnostic
model. This finding could facilitate the earlier diagnosis of ARM
and improve the sensitivity of the assessment of changes in
retinal function after treatment.
MATERIALS AND METHODS
Participants
The cohort comprised 31 patients with ARM, recruited from the Eye
Unit at the University Hospital of Wales, Cardiff. The inclusion criteria
were: age at least 55 years, a corrected VA of 0.5 logMAR (logarithm of
the minimum angle of resolution), or better in the test eye, and a
diagnosis of ARM according to the International Classification and
Grading System,3 with no coexisting ocular–fundal abnormality. A
diagnosis of ARM required the presence of one or more of the follow-
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ing macular signs: drusen and focal hyperpigmentation or hypopig-
mentation, in the absence of geographic atrophy or exudative AMD.
The presence of small (63 m), hard drusen alone within the macular
area was not considered to be diagnostic of ARM. Diagnosis was based
on the appearance of 30° diameter stereo fundus images (3-DX Stereo
Disc Camera; Nidek Co. Ltd., Gamagori, Japan), which were obtained
through dilated pupils on the day that the ERGs were recorded.
Representative fundus photographs of the test eye of eight participants
with ARM are shown in Figure 1, along with the corresponding visual
acuities.
The control group consisted of 27 individuals recruited from the
Eye Clinic at Cardiff University, all of whom had a corrected visual
acuity of logMAR 0.2 or better and a normal retinal and optic nerve
head appearance in both eyes.
Potential recruits to either group were excluded from the study if
they had a history of systemic disease (or medication) likely to affect
retinal function, a history of photosensitive epilepsy, or media opaci-
ties detrimental to the acquisition of clear fundus images. The clinical
characteristics of the groups are described in Table 1. In all cases, the
eye chosen for ERG recording was the eye with ARM or, in the case of
bilateral ARM and control subjects, the eye with the better visual
acuity.
The study adhered to the Tenets of the Declaration of Helsinki and
was approved by the South East Wales Research Ethics Committee.
Written, informed consent was obtained from all participants before
participation in the study.
ERG Recording
Pupils were dilated with 1 drop of 1.0% tropicamide before ERG
recording. Silver-silver chloride, 9-mm diameter, touchproof skin elec-
trodes (Viasys Healthcare Ltd., Warwick, UK) were applied to the
midfrontal and outer canthus positions, acting as ground and reference
electrodes, respectively. Skin electrodes were attached using surgical
tape (Blenderm; 3M, St. Paul, MN) after preparing the skin with gel
(Nuprep; D. O. Weaver & Co., Aurora, CO), and filling electrode cups
with electrolyte electrode gel (Teca, Pleasantville, NY). A DTL fiber
active electrode35 (Unimed Electrode Supplies, Surrey, UK) was posi-
tioned in the lower fornix of the test eye. All ERGs were recorded
without local anesthetic or methylcellulose solution.
An evoked potential monitoring system (Medelec Synergy EP; Ox-
ford Instruments Medical, Surrey, UK) was used to record all ERGs. All
responses were band-pass filtered from 1 to 100 Hz and digitally
averaged. One hundred sweeps were averaged per trace. An artifact-
reject setting allowed the exclusion of traces contaminated by blinks or
eye movements.
Stimuli were generated with a miniature Ganzfeld LED stimulator.
The head stage of the stimulator comprised an array of amber LEDs
(peak   595 nm, half-height bandwidth  17 nm) set behind a
circular diffuser. All stimuli had an average luminance of 30 phot cd 
m2 (3.18 log phot Td, assuming a pupil diameter of 8 mm, and making
no correction for the Stiles-Crawford effect). The stimulus subtended
20° at the eye, viewed from a distance of 14 cm and was set within a
luminance-matched Ganzfeld surround to suppress responses from the
peripheral retina. All luminances were measured with a light meter
(LS-110; Konica Minolta, Osaka, Japan). Conversion from photopic to
scotopic luminances was calculated according to data supplied by
Wyszeki and Stiles.36 Since this conversion factor is only strictly appli-
cable to monochromatic light sources, an approximation of scotopic
luminance was obtained by using the wavelength of peak LED trans-
mission in all calculations.
Flicker ERGs were recorded in response to a square-wave stimulus
presented at a temporal frequency of 41 Hz (flash duration 12 ms).
Transient responses were also obtained, using a square-wave, 5-Hz
stimulus (flash duration, 100 ms). A 50-ms time base was used for
recording the 41-Hz ERG, and a 200 ms time base was used for
recording the 5-Hz ERG. Examination of the energy spectrum of the
focal 5-Hz ERG indicates that the components that comprise the a- and
b-waves of the response are at frequencies lower than 45 Hz. Higher-
frequency signals may be attributed to oscillatory potentials and extra-
neous noise. Therefore, the signal-to-noise ratio of the a- and b-wave
components of the ERG was improved by using Fourier analysis to
FIGURE 1. Photographs of the fundus appearance of eight typical
participants with ARM, along with their logMAR visual acuities.
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remove frequencies higher than 45 Hz. Fourier analysis was imple-
mented in commercial software (Excel 2003; Microsoft. Redmond,
WA). First, the average ERG signal obtained during the first 6 ms was
set to 0 V, and baseline drift was corrected by subtracting a ramp
function such that the final 20 ms of the trace also had an average
amplitude of 0 V. Subsequently, the Fourier coefficients for the first
nine harmonics were determined, and these were used to reconstruct
the signal. In this way, frequencies above 45 Hz (the ninth harmonic)
were removed from the signal. The measurement of implicit times and
amplitudes of the a- and b-waves was objectified by measuring the
minima and maxima within a specified time window of 15 to 30 ms
(a-wave) and 35 to 50 ms (b-wave). The amplitude and time-to-peak of
the first harmonic of the focal 41-Hz ERG were also determined by
using Fourier analysis.
Full-field ERG responses were also recorded for the same stimuli
(30 phot cd  m2, temporal frequency 5 and 41 Hz). This allowed the
determination of a focal-to-full-field amplitude ratio.
The amber stimulus of 30 phot cd  m2 (1.44 scot cd  m2) used
to record all focal cone responses had an average illuminance of 1.86
log scot Td (assuming an 8-mm pupil). Thus, the 5-Hz ERG may have
included a small rod contribution, as the rods do not saturate until 3.30
log scot Td.37 A control study, however, suggested that any rod con-
tribution was minimal. This study recorded both the 41- and 5-Hz focal
cone ERGs from a healthy normal subject (AMB), and then again with
the same stimuli presented on a rod-saturating blue background which
raised the scotopic illuminance to 3.30 log scot Td. The adapting
background had the potential to desensitize the rods and the cones;
but, since rods do not contribute to ERGs recorded with stimuli of high
temporal frequencies,38 any reduction in amplitude of the 41-Hz ERG
when the background was added must have been due to desensitiza-
tion of the cones alone. If the rods were contributing to the 5-Hz focal
cone ERG, it was hypothesized that the transient response would be
reduced in amplitude to a greater extent than would the flicker re-
sponse by the introduction of the background. The 5- and 41-Hz ERGs
were reduced by a comparable amount (24% and 32%, respectively),
suggesting that the rod contribution to the 5-Hz ERG was minimal.
Recording of the ERG Photostress Test
The ERG photostress test involved the recording of a baseline 41-Hz
focal cone ERG (the average of 200 sweeps) to determine the pre-
bleach response amplitude. The eye was subsequently light-adapted to
a bright white background (5.6 log phot Td) for a period of 2 minutes.
Because of the Stiles-Crawford effect, not all light reaching the retina
through the dilated pupil is effectively absorbed by the directionally
sensitive cones. The effective retinal illuminance was calculated as 5.3
phot Td, which bleached approximately 86% of the cone visual pig-
ment.39 The bleaching light, which had a central fixation cross, sub-
tended 40° at the eye and was presented within the Ganzfeld bowl,
immediately below the flickering amber stimulus. After cessation of the
bleaching, the participant redirected his or her gaze to the flickering
stimulus, and 100 sweeps were averaged every 20 seconds for 5
minutes. This procedure allowed approximately 10 seconds for the
participant to relax between each recording period.
Fourier analysis was used to determine the phase and amplitude of
the first harmonic of the prebleach 41-Hz ERG. The amplitude of
postbleach ERG signals was also determined with Fourier analysis, but
the phase was locked to match that of the prebleach signal. Each
participant’s amplitude recovery data was then modeled, on a least-
squares fit basis, by using a first-order exponential function in the form:
at  ao1 B expt/, (1)
FIGURE 2. Superimposed raw 5-Hz
focal cone ERGs of all control sub-
jects (A), and the individual traces of
all participants with ARM (B). Most,
but not all, participants were shown
to have clear a- and b-waves, but
there was marked between-partici-
pant variability in response ampli-
tude.
TABLE 1. Summary of Characteristics of Participant Groups
Control
(n  27)
ARM
(n  31)
Univariate Comparison
of Groups
Age, mean years (SD) 71.7 (7.0) 72.4 (8.0) P  0.71
Gender (% female) 46 52 P  0.72
Acuity of test eye, mean logMAR (SD) 0.04 (0.07) 0.20 (0.15) P  .001
Diagnosis of ARM in test eye 0 31
Diagnosis in fellow eye
ARM 0 12
Geographic atrophy 0 8
Exudative AMD 0 11
There was no significant difference in age or gender balance between the control and ARM groups.
Visual acuity was significantly worse in the ARM group than in the control group.
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where a(t) is the amplitude of the ERG, ao is the unbleached ampli-
tude, B is the initial bleaching,  is the time constant of recovery, and
t is the time after bleaching. Assuming that the final, recovered ampli-
tude of the first harmonic would be approximately the same as the
prebleach value, two prebleach values were plotted on the curves at a
very late time, 24 hours after bleaching, where recovery was assumed
to be complete. When fitting the model, B was constrained to be
within the range of 0 to 1, and ao and were free parameters of the fit.
The parameter assessed for all participants was the time constant of
recovery (). This constant was converted to a rate-of-recovery param-
eter (1/, min1). A smaller value for 1/ indicated a slower rate of
recovery.
Analysis
The distribution of the data for each of the electrophysiological param-
eters was tested for normality by using the Shapiro-Wilkes W test. The
ability of each individual parameter to distinguish between the subjects
with ARM and the normal control subjects was determined by using an
unpaired t-test for normally distributed data or, in the case of data that
were not normally distributed, the Mann-Whitney test. P  0.05 was
taken as representing a significant difference. Individual receiver op-
erating characteristic (ROC) curves were constructed for those param-
eters that showed a significant difference between the ARM and nor-
mal control groups, and the area under the curve was calculated.
To identify independent predictors of ARM and to exploit the full
diagnostic potential of the test battery, a logistic regression analysis
was undertaken, in which electrophysiological parameters were used
as continuous explanatory variables. To avoid including all the vari-
ables and run the risk of overfitting the logistic regression model, only
those parameters that yielded a statistically significant difference be-
tween the two groups in the univariate analysis were included in the
logistic regression analysis. Initially, each variable in the regression
model was considered individually before running a backward step-
wise analysis based on the method of maximum likelihood estimation.
Explanatory variables were removed from the model if their signifi-
cance exceeded P  0.1. The goodness of fit of the regression model
was evaluated by plotting an ROC curve and determining the area
under the curve. All statistical analysis was undertaken with commer-
cial software (SPSS ver. 12; SPSS, Chicago, IL).
RESULTS
The raw transient (5 Hz) and steady state (41 Hz) focal cone
ERG responses from all control subjects and participants with
ARM are shown in Figures 2 and 3, respectively. The between-
participant variability in the amplitude of the responses is
apparent, within both the control and ARM groups. To reduce
FIGURE 3. Superimposed raw 41-Hz
focal cone ERGs of all control sub-
jects (A) and the individual traces of
all participants with ARM (B). Two
clear response peaks were shown in
most, but not all, participants. There
was marked between-participant
variability in response amplitude.
TABLE 2. Mean Amplitudes and Implicit Times of the 5- and 41-Hz Focal Cone ERGs, Mean Time Constants of Recovery for the ERG
Photostress Test, and the Statistical Significance of the Univariate Analysis between the Group with ARM and the Normal Control Group for
Each Parameter
Control ARM
Univariate Comparison
of Groups
Area under
ROC Curve
5-Hz ERG
a-Wave implicit time (ms) 22.50 (0.29) 24.07 (0.31) P  0.002 0.74
a-Wave amplitude (V) 1.52 (0.14) 1.30 (0.11) P  0.21
b-Wave implicit time (ms) 42.66 (0.33) 45.37 (0.49) P  0.001 0.77
b-Wave amplitude (v) 3.96 (0.28) 3.42 (0.24) P  0.15
Focal: full-field a-wave amplitude 0.1078 (0.0096) 0.0907 (0.0071) P  0.15
Focal: full-field b-wave amplitude 0.1342 (0.0065) 0.1177 (0.0080) P  0.12
41-Hz ERG
Implicit time (ms) 11.60 (0.20) 13.21 (0.38) P  0.001 0.73
Amplitude (V) 1.98 (0.17) 1.28 (0.16) P  0.003 0.73
Focal: full-field amplitude 0.153 (0.013) 0.101 (0.010) P  0.001 0.74
Dynamic Focal Cone ERG
Rate of recovery (1/ min1) 0.372 (0.074) 0.183 (0.048) P  0.002 0.74
The area under the ROC curve is also given for all parameters that differ significantly between groups on univariate analysis. The values in
parentheses denote the SE of the mean.
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this variability, focal-to-full-field amplitude ratios were calcu-
lated for each individual.
After Fourier analysis and removal of signals above 45 Hz,
the mean amplitudes and implicit times of both the 5- and
41-Hz focal cone ERGs were obtained and are summarized in
Table 2. The parameters that exhibited a statistically significant
difference between the control and ARM groups were: the a-
and b-wave implicit times of the transient response and the
time-to-peak, peak-to-trough amplitude, and focal-to-full-field
amplitude ratio of the first harmonic of the steady state re-
sponse.
When individual ROC curves were constructed for these
parameters, the transient focal cone ERG b-wave implicit time
was marginally the best at discriminating participants with
ARM from the normal control subjects, yielding an area under
the curve of 0.77. However, the transient focal cone ERG
a-wave implicit time and the 41-Hz focal cone ERG amplitude,
time-to-peak, and focal to full-field amplitude ratio all elicited a
comparable area under the ROC curve (see Table 2).
To determine the extent to which the use of a focal to
full-field amplitude ratio reduces between-participant variabil-
ity, the coefficient of variation was calculated for both the
amplitude and the ratio parameters. The parameter that was
most affected by the calculation of an amplitude ratio was the
5-Hz focal cone ERG b-wave, which showed a marked reduc-
tion in the coefficient of variation, both in the control subjects
(37%–23%) and in the participants with ARM (39%–33%).
There was a smaller reduction in the coefficient of variation of
FIGURE 4. Typical ERG photostress
test recovery data from two control
subjects (top traces) and two partic-
ipants with ARM (bottom traces).
The ERG is markedly reduced in am-
plitude in all participants immedi-
ately after cessation of bleaching. Re-
covery of ERG amplitude followed an
exponential time course. The X
marker on each trace indicates the
amplitude before bleaching.
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the 5-Hz a-wave amplitude when a ratio was calculated (con-
trol, 48%–45%; ARM, 45%–44%). The variability of the 41-Hz
amplitude measures was reduced considerably in the ARM
group (72%–57%), but was not improved in the control group
(45%–46%). Nevertheless, the calculation of the amplitude
ratio for the focal 41-Hz ERG still slightly improved the sepa-
ration between groups (the area under the ROC curve changed
from 0.73 to 0.74 with the calculation of the ratio).
Typical ERG photostress test responses from two control
subjects and two participants with ARM are shown in Figure 4.
The recovery data show that the ERG was virtually extin-
guished immediately after the bleaching, and gradually recov-
ered over the following minutes. Participants with ARM tended
to show a slower rate of recovery of ERG amplitude after light
adaptation (Fig. 5). This was reflected in the significantly lower
group-averaged rate of recovery in the ARM group compared to
normal control subjects (Table 2). The large area under the
ROC curve for this parameter (0.74) indicated that it provided
good separation between the groups. Nine individuals with
ARM and two control subjects had a particularly marked delay
in recovery, failing to show any recovery within the 5-minute
recording period. There was no significant correlation be-
tween visual acuity and rate of recovery in either the control
(Spearman’s rho  0.11; P  0.59) or ARM (Spearman’s
rho  0.19; P  0.30) group.
Logistic Regression Analysis
The univariate analysis identified six parameters that were
significantly different between groups: the a- and b-wave im-
plicit times (5-Hz ERG); the implicit time, amplitude, and focal-
to-full-field amplitude ratio (41-Hz ERG), and the rate of recov-
ery of the ERG photostress test. These parameters were used as
explanatory variables in the logistic regression analysis. The
parameters of the best-fitting logistic regression model, shown
in Table 3, were: the rate of recovery of the ERG photostress
test, the b-wave implicit time of the 5-Hz focal cone ERG and
the implicit time of the 41-Hz focal cone ERG. The area under
the ROC curve was 0.84, indicating a good model fit, and, with
a cutoff probability of P  0.5, the sensitivity and specificity of
the model were 77% and 85%, respectively.
DISCUSSION
In this study, that the recovery of the ERG photostress test was
markedly slower in ARM and provides compelling evidence
that the rate of recovery is an important electrophysiological
predictor of ARM. In the univariate analysis, the rate of recov-
ery of the ERG photostress test produced an impressive area
under the ROC curve. Logistic regression analysis identified the
ERG photostress test as an independent predictor of ARM. The
logistic regression model enabled the exploitation of the full
diagnostic potential of the entire test battery, providing an
excellent area under the ROC curve and was able to distinguish
between groups with a high sensitivity and specificity (77%
and 85%, respectively).
The multivariate analysis identified three independent pre-
dictors of ARM, specifically: two latency measures and the ERG
photostress test rate of recovery. This may reflect the presence
of distinct pathogenic mechanisms.
A subset of nine individuals with ARM showed no recovery
of ERG amplitude at all during the 5 minutes of recording after
cessation of bleaching. Five of these participants had exudative
AMD in the fellow eye. Given the known higher incidence of
onset of choroidal neovascularization in the fellow eye of
individuals with unilateral wet AMD,40–42 this finding suggests
that there is a slower rate of recovery in eyes with an increased
risk of exudative changes. This result could indicate a prognos-
tic role for the ERG photostress test in identifying, at an early
stage, patients who may be suitable for future treatment inter-
ventions, such as photodynamic therapy.
The steady state 41-Hz ERG is largely dependent on bipolar
cell activity.31–34 However, the recovery of the 41-Hz ERG after
exposure to intense light is primarily dependent on cone pho-
topigment regeneration (although the nonlinear relation be-
tween photopigment recovery and voltage indicates that this
relationship is a complex one).30,43 This assertion is based on
the fact that the recovery time constant obtained using the ERG
photostress test is very similar to that for cone photopigment
regeneration based on the measurement of photopic a-wave
amplitudes.30,43 Therefore, it is likely that the slower rate of
recovery of the ERG photostress test reflects a deficit in the
ability of the outer retina to regenerate cone photopigment. A
delay in cone dark adaptation in ARM has been reported in the
psychophysical literature,44–47 however, the ERG photostress
FIGURE 5. Histogram showing the distribution of rates of recovery of
the ERG photostress test for control subjects and participants with
ARM. Note that subjects with ARM tend to have a slower rate of
recovery.
TABLE 3. Parameters of the Best-Fitting Logistic Regression Model
Variable
Regression
Coefficient  SEM Significance
Odds Ratio
(95% CI)
Rate of recovery (1/ min1) 2.44  1.16 0.04 0.09 (0.013–0.591)
Focal b-wave implicit time (ms) 0.49  0.18 0.007 1.64 (1.22–2.21)
Focal 41-Hz implicit time (ms) 0.43  0.23 0.07 1.53 (1.04–2.25)
Constant 26.08  7.94 0.001
Three parameters were identified as contributing to the best-fitting model, which yielded a sensitivity
and specificity of 77% and 85%, respectively, at distinguishing between ARM and normal control groups.
The area under the ROC curve was 0.84.
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test provides a unique means of objectively assessing this
impairment at an outer retinal level.
Retinal adaptation is a complex process that requires the
provision of retinoids and metabolites by the choroidal blood
supply. These materials must be transported across Bruch’s
membrane to the RPE and photoreceptors where the regener-
ation of photopigment occurs.48 Structural changes to Bruch’s
membrane, such as thickening and the accumulation of hydro-
phobic materials,49 and atrophy of the choriocapillaris50 may
limit the rate at which these essential molecules reach the
outer retina in ARM, thus causing slowed adaptation kinet-
ics.23,51 The alteration to the permeability of Bruch’s mem-
brane in ARM not only affects the rate of photopigment regen-
eration, but has also been linked to the onset of choroidal
neovascularization, through the disruption of the transport of
RPE-derived growth factors to the choriocapillaris via Bruch’s
membrane.52 This common causal factor may explain the link
between slower cone dark adaptation and an increased risk of
exudative AMD.
Participants in this study were classified as normal or having
ARM on the basis of fundus appearance and visual acuity,
alone. It is noteworthy that two participants within the control
group showed no recovery in the 5-minute recording period.
This suggests that the ERG photostress test highlights func-
tional abnormalities that are not reflected in the fundus appear-
ance. Longitudinal evaluation would determine whether the
electrophysiological tests are detecting participants within the
control group who are at a subclinical stage of ARM.
Abnormal adaptation kinetics have been reported in other
macular conditions, such as Sorsby’s fundus dystrophy,53–56
idiopathic central serous chorioretinopathy,57,58 Stargardt’s
disease, and fundus flavimaculatus (Marinescu AIC et al. IOVS
2001;42:ARVO Abstract 351).59–62 It is important, therefore,
that the full clinical profile of the patient be considered if the
ERG photostress test is to be used diagnostically. For example,
the discrepancy in the usual age of onset of these other mac-
ular conditions (typically before the fifth decade of life) and
ARM (typically in the sixth decade or above) should be taken
into account in the differential diagnosis. Further investigation
using the ERG photostress test will determine the potential for
the assessment of patients with macular conditions other than
ARM.
To conclude, the ERG photostress test rate of recovery was
found to be significantly reduced in subjects with ARM and was
a significant predictor of ARM in the best-fitting logistic regres-
sion model. Improved assessment of the functional integrity of
the central retina will facilitate both evaluation of therapeutic
interventions and earlier identification of those with a height-
ened risk of ARM.
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